Back to 
Two Sigma Advisers, LP
Two Sigma Advisers, LP
VIVO
Showing 0 of 18 quarters
Position history for Two Sigma Advisers, LP's holdings in MERIDIAN BIOSCIENCE INC
As of its Q4 2022 13F, Two Sigma Advisers held 265,800 shares of VIVO (Meridian Bioscience), worth $8.8M. Two Sigma Advisers' 13F filings listed VIVO from Q4 2018 to Q4 2022, 17 quarterly filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.